Genitourinary Malignancies Branch

Chief
James L. Gulley, M.D., Ph.D.
Deputy Chief
William Douglas Figg, Sr., Pharm.D.

The Genitourinary Malignancies Branch focuses on investigating the biology of genitourinary cancers, developing new strategies for treating those cancers, and evaluating these new therapeutic approaches through science-driven clinical research. These clinical trials investigate novel approaches in immunotherapy, hormonal therapy, chemotherapy combinations, and small-molecule targeted therapy. This website is designed to provide all interested parties--referring physicians, cancer patients or family members interested in participating in a clinical trial, or researchers looking for collaborative opportunities--with the information they need to get started.

About

The Genitourinary Malignancies Branch focuses on investigating the biology of genitourinary cancers, developing new strategies for treating those cancers, and evaluating these new therapeutic approaches through science-driven clinical research. These clinical trials investigate novel approaches in immunotherapy, hormonal therapy, chemotherapy combinations, and small-molecule targeted therapy. This website is designed to provide all interested parties--referring physicians, cancer patients or family members interested in participating in a clinical trial, or researchers looking for collaborative opportunities--with the information they need to get started.

Clinical Trials

Directory

Contact Info

Genitourinary Malignancies Branch
Center for Cancer Research
National Cancer Institute
Building 10, Room 12N226
Bethesda, MD 20892
301-496-4916